Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
PMID: 38411348

Abstract

BACKGROUND: Artificial intelligence (AI) shows promising potential to enhance human decision-making as synergistic augmented intelligence (AuI), but requires critical evaluation for skin cancer screening in a real-world setting.

Authors

  • Elisabeth Victoria Goessinger
    Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Johannes-Christian Niederfeilner
    Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Sara Cerminara
    Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Julia-Tatjana Maul
    Faculty of Medicine, University of Zürich, Zürich, Switzerland.
  • Lisa Kostner
    Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Michael Kunz
    Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Stephanie Huber
    Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, Speisinger Straße 109, 1130, Vienna, Austria.
  • Emrah Koral
    Department of Dermatology, University Hospital Basel, Basel, Switzerland.
  • Lea Habermacher
    Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Gianna Sabato
    Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Andrea Tadic
    Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Carmina Zimmermann
    Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Alexander Navarini
    Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
  • Lara Valeska Maul
    Department of Dermatology, University Hospital Basel, Basel, Switzerland.

Keywords

External Resources

Popular Topics
Recent Journals